LOS ANGELES, April 28 (Xinhua) -- Moderna on Thursday asked the U.S. Food and Drug Administration (FDA) to authorize its COVID-19 vaccine for children 6 months to under 6 years of age.
The two-dose vaccine was about 51 percent effective against infection from the Omicron variant in children from 6 months to under 2 years old, and about 37 percent effective among 2 to under 6 years old, according to Moderna.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!